Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Nordic Drugs Aktiebolag
AB
Active
Org 5565055141
Södergatan 26, 211 34
Malmö
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 1995
25 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Nordic Drugs Aktiebolag
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
109M
218M
327M
436M
240M
2021
300M
2022
338M
2023
363M
2024
379M
2025
EBITDA
SEK millions
0M
12M
23M
35M
46M
-5M
2021
-4M
2022
14M
2023
38M
2024
40M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
240 041
300 076
337 525
363 312
378 808
Staff expenses
—
—
—
—
—
EBITDA
−4 558
−4 034
13 994
38 063
40 074
Depreciation & amort.
—
—
—
—
—
EBIT
−4 558
−4 034
13 994
38 063
40 074
Net financials
1 131
1 065
910
−1 537
−1 743
Profit before tax
−423
4 252
14 798
44 997
46 260
Tax
2 950
−2 545
−5 346
−9 949
−9 734
Net profit
2 527
1 707
9 452
35 048
36 526
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
148 441
139 098
170 179
186 163
209 253
Equity
69 584
71 290
80 742
115 790
152 315
Long-term debt
0
0
0
0
0
Short-term debt
49 744
45 916
67 440
55 450
49 945
Total debt
49 744
45 916
67 440
55 450
49 945
Financial ratios
5-year trend
EBITDA margin
10.6%
This company
15.8%
Market median
-33% vs market
2021
2025
Equity ratio
72.8%
This company
38.2%
Market median
+91% vs market
2021
2025
Return on equity
24.0%
This company
18.4%
Market median
+30% vs market
2021
2025
Net profit margin
9.6%
This company
8.1%
Market median
+19% vs market
2021
2025
Asset turnover
1.81×
This company
1.12×
Market median
+62% vs market
2021
2025
Debt / equity
0.37×
This company
0.62×
Market median
+40% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Nordic Drugs Aktiebolag
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
